© Reuters. FILE PHOTO: The logo of Bayer AG is pictured at the facade of the historic headquarters of the German pharmaceutical and chemical maker in Leverkusen, Germany, April 27, 2020. REUTERS/Wolfgang Rattay/File Photo
(Reuters) – Bayer (OTC:) on Tuesday reported a net loss of 1.89 billion euros ($2.08 billion) for the second quarter, weighed down by 2.3 billion euros in impairment charges.
The statement based on audited results came after the German drugs and pesticides maker in July cited preliminary figures as showing expected goodwill impairments worth about 2.5 billion euros, leading to a second-quarter net loss of 2 billion euros.
